HAPPENING NOW
Health
Blood-based test can predict risk of developing symptoms of Alzheimer's up to a decade early
A blood test for the biomarker phosphorylated tau 217 (p-tau217) recently received federal clearance, but questions have emerged about th…
AI Summary
A blood test for the biomarker phosphorylated tau 217 (p-tau217) recently received federal clearance, but questions have emerged about the extent to which such tests can accurately predict whether a cognitively healthy individual will develop cognitive impairment—a key symptom of Alzheimer's disease.
Read full article on MedicalxpressAI summaries can be wrong sometimes—always verify important details using the source article.
Enjoyed this article? Consider supporting HappeningNow to help keep independent AI-powered news analysis moving forward. Your contribution helps cover infrastructure, AI summaries, and continued platform development.
Support HappeningNowMore from Health
Continue reading recent Health coverage
- I investigated Palantir’s foothold in the British state – and what I found should worry us all | Peter GeogheganContinue reading
- Why are family doctors leaving the workforce? Retirement, burnout creating a US primary care 'brain drain'Continue reading
- Lettuce suspected in growing multistate Cyclospora outbreakContinue reading